These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 22411971

  • 21. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions.
    Kaesemeyer WH, Caldwell RB, Huang J, Caldwell RW.
    J Am Coll Cardiol; 1999 Jan; 33(1):234-41. PubMed ID: 9935036
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
    Bulhak AA, Sjöquist PO, Xu CB, Edvinsson L, Pernow J.
    Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN, Zhou ZM, Chen P.
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
    [Abstract] [Full Text] [Related]

  • 29. Opioid receptor agonist Eribis peptide 94 reduces infarct size in different porcine models for myocardial ischaemia and reperfusion.
    Karlsson LO, Grip L, Bissessar E, Bobrova I, Gustafsson T, Kavianipour M, Odenstedt J, Wikström G, Gonon AT.
    Eur J Pharmacol; 2011 Jan 25; 651(1-3):146-51. PubMed ID: 21093430
    [Abstract] [Full Text] [Related]

  • 30. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.
    Puccetti L, Bruni F, Bova G, Cercignani M, Palazzuoli A, Console E, Auteri A, Pasqui AL.
    Nutr Metab Cardiovasc Dis; 2001 Dec 25; 11(6):378-87. PubMed ID: 12055702
    [Abstract] [Full Text] [Related]

  • 31. [Effects and potential mechanisms of short-term use of simvastatin on myocardial no-reflow after ischemia-reperfusion in rats].
    Liu YH, Zhang M, Liu LM, Zhou X, Jiao ZQ, Li YM, Pang W.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Aug 25; 36(8):729-34. PubMed ID: 19100117
    [Abstract] [Full Text] [Related]

  • 32. Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.
    Bulhak AA, Gourine AV, Gonon AT, Sjöquist PO, Valen G, Pernow J.
    Acta Physiol Scand; 2005 Feb 25; 183(2):151-9. PubMed ID: 15676056
    [Abstract] [Full Text] [Related]

  • 33. Comparison of cardioprotective efficacy resulting from a combination of atorvastatin and ischaemic post-conditioning in diabetic and non-diabetic rats.
    Fan Y, Yang S, Zhang X, Cao Y, Huang Y.
    Clin Exp Pharmacol Physiol; 2012 Nov 25; 39(11):938-43. PubMed ID: 23106693
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
    McKenney JM, Jones PH, Adamczyk MA, Cain VA, Bryzinski BS, Blasetto JW, STELLAR Study Group.
    Curr Med Res Opin; 2003 Nov 25; 19(8):689-98. PubMed ID: 14687438
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of L-arginine on the endogenous angiogenic response in a model of hypercholesterolemia.
    Nakai Y, Voisine P, Bianchi C, Xu SH, Feng J, Malik T, Rosinberg A, Sellke FW.
    Surgery; 2005 Aug 25; 138(2):291-8. PubMed ID: 16153439
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Simvastatin enhances the antihypertensive effect of ramipril in hypertensive hypercholesterolemic animals and patients. Possible role of nitric oxide, oxidative stress, and high sensitivity C-reactive protein.
    Abdel-Zaher AO, Elkoussi AE, Abudahab LH, Elbakry MH, Elsayed EA.
    Fundam Clin Pharmacol; 2012 Dec 25; 26(6):701-11. PubMed ID: 21913974
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.